Not applicableLooking for participantsNCT03504007What this trial is testingRegistry of Patients Prescribed AnticoagulationWho this might be right forAcute Deep Vein ThrombosisAcute Pulmonary Embolism Mayo Clinic 10,000
Large-scale testing (Phase 3)Study completedNCT02798471What this trial is testingHokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)Who this might be right forVenous Thromboembolism (VTE)Pulmonary EmbolismDeep Vein Thrombosis (DVT) Daiichi Sankyo 290
Early research (Phase 1)Study completedNCT01826266What this trial is testingEffects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of EdoxabanWho this might be right forAnticoagulant ReversalReversal of Edoxaban Induced Anticoagulation Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 83
Not applicableWithdrawnNCT03537521What this trial is testingReversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New AntidotsWho this might be right forSevere BleedingUrgent Surgery Cardioangiologisches Centrum Bethanien
Not applicableStudy completedNCT04121767What this trial is testingSafety and Efficacy of Edoxaban in Thoracoscopic AblationWho this might be right forAtrial FibrillationAnticoagulants and Bleeding Disorders Samsung Medical Center 60
Large-scale testing (Phase 3)Study completedNCT02942576What this trial is testingEdoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter AblationWho this might be right forAtrial Fibrillation Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 632
Post-approval studies (Phase 4)Active Not RecruitingNCT03129490What this trial is testingThe Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial FibrillationWho this might be right forAtrial FibrillationAtrial Flutter Herlev and Gentofte Hospital 11,000
Not applicableStudy completedNCT03247582What this trial is testingEdoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)Who this might be right forAtrial Fibrillation Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo Company 234
Not applicableStudy completedNCT01722786What this trial is testingReversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K AntagonistsWho this might be right forSevere BleedingUrgent Surgery Cardioangiologisches Centrum Bethanien 272
Not applicableLooking for participantsNCT06957366What this trial is testingPerioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive ProcedureWho this might be right forAtrial Fibrillation (AF)VTE McMaster University 920
Not applicableEnded earlyNCT03977363What this trial is testingThe Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register)Who this might be right forAtrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis CHAD 25
Testing effectiveness (Phase 2)Study completedNCT01203098What this trial is testingA Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyWho this might be right forVenous ThromboembolismThromboembolismThrombosis+3 more Daiichi Sankyo Co., Ltd. 264
Large-scale testing (Phase 3)Study completedNCT03244319What this trial is testingExplore the Efficacy and Safety of edoxabaN in Patients After Heart Valve Repair or Bioprosthetic vaLve Replacement (ENAVLE Trial)Who this might be right forMV(Mitral Valve) Repair Yonsei University 220
Large-scale testing (Phase 3)Study completedNCT01181167What this trial is testingDU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyWho this might be right forPreventionVenous Thromboembolism Daiichi Sankyo Co., Ltd. 610
Not applicableStudy completedNCT03524924What this trial is testingEdoxaban and Frailty in Senior IndividualsWho this might be right forAtrial Fibrillation University of Padova 180
Not applicableUnknownNCT06285942What this trial is testingEdOxaban in fRagIle Patients With Percutaneous Endoscopic GAstrostoMy and atrIal fIbrIllationWho this might be right forAtrial FibrillationFragility Azienda Ospedaliero Universitaria Maggiore della Carita 168
Post-approval studies (Phase 4)Study completedNCT03284827What this trial is testingAnticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve ReplacementWho this might be right forAortic Valve Stenosis Duk-Woo Park, MD 235
Large-scale testing (Phase 3)Study completedNCT00986154What this trial is testingComparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).Who this might be right forVenous ThromboembolismDeep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+2 more Daiichi Sankyo 8,292
Post-approval studies (Phase 4)Study completedNCT03840291What this trial is testingResolution of Thrombi in Left Atrial Appendage With EdoxabanWho this might be right forAtrial FibrillationLeft Atrial Appendage Thrombosis Keimyung University Dongsan Medical Center 36
Large-scale testing (Phase 3)UnknownNCT04171726What this trial is testingRotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve ImplantationWho this might be right forAortic Valve Stenosis Erasmus Medical Center 100